Literature DB >> 2190467

Diabetic hypouricemia as an indicator of clinical nephropathy.

M Shichiri1, H Iwamoto, F Marumo.   

Abstract

We studied the possible association of the low serum uric acid level with incipient diabetic nephropathy in non-insulin-dependent diabetes mellitus (NIDDM). Of 201 NIDDM patients without a diminished glomerular filtration rate, 66 patients (32.8%) showed moderate hypouricemia of less than the mean-1 SD of 201 nondiabetic controls. Thirteen (6.5%) showed marked hypouricemia of less than the mean-2 SD. Hypouricemic patients showed normal daily urinary urate excretion with a markedly elevated urate clearance/creatinine clearance ratio. Most were under poor glycemic control, and presented either negative or intermittent clinical proteinuria. However, neither poor glycemic control, nor the presence of proteinuria or retinopathy alone significantly affected the serum uric acid level of the whole diabetic population. The glomerular filtration rate was determined in comparable groups of diabetic patients with hypouricemia and nonhypouricemic diabetic controls. The hypouricemic group showed a significantly higher endogenous creatinine clearance and lower serum beta-2-microglobulin levels than the nonhypouricemic group. These findings suggest that the hypouricemic group had a higher glomerular filtration rate. Long-term observation of up to 12 years of the above patients revealed that, in most patients, persistent hypouricemia was observed prior to the initial appearance of intermittent proteinuria. We hypothesize that glomerular hyperfiltration also occurs in NIDDM and that it lowers the serum uric acid by increasing the renal clearance of urate. Hypouricemia may also predict the future progression of incipient nephropathy in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190467     DOI: 10.1159/000168065

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

Review 1.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

Review 2.  Linking uric acid metabolism to diabetic complications.

Authors:  Akifumi Kushiyama; Kentaro Tanaka; Shigeko Hara; Shoji Kawazu
Journal:  World J Diabetes       Date:  2014-12-15

Review 3.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

4.  Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Authors:  Mehmet Kanbay; Constance Xhaard; Edith Le Floch; Claire Dandine-Roulland; Nicolas Girerd; João Pedro Ferreira; Jean-Marc Boivin; Sandra Wagner; Delphine Bacq-Daian; Jean-François Deleuze; Faiez Zannad; Patrick Rossignol
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

5.  Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population.

Authors:  Dandan Yan; Yinfang Tu; Feng Jiang; Jie Wang; Rong Zhang; Xue Sun; Tao Wang; Shiyun Wang; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

6.  Association between Serum Uric Acid Level and ESRD or Death in a Korean Population.

Authors:  Kipyo Kim; Suryeong Go; Hyung Eun Son; Ji Young Ryu; Hajeong Lee; Nam Ju Heo; Ho Jun Chin; Jung Hwan Park
Journal:  J Korean Med Sci       Date:  2020-07-20       Impact factor: 2.153

7.  Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study.

Authors:  Fengqin Li; Hui Guo; Jianan Zou; Weijun Chen; Yijun Lu; Xiaoli Zhang; Chensheng Fu; Jing Xiao; Zhibin Ye
Journal:  BMC Nephrol       Date:  2018-04-24       Impact factor: 2.388

8.  Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients.

Authors:  Azhar Hussain; Omar B Latiwesh; Farwa Ali; Mustafa Y G Younis; Jamal A Alammari
Journal:  Cureus       Date:  2018-08-17

9.  Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice.

Authors:  Yu Mizuno; Takeshi Yamamotoya; Yusuke Nakatsu; Koji Ueda; Yasuka Matsunaga; Masa-Ki Inoue; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Takako Kikuchi; Masahiro Takahashi; Kenichi Morii; Kensuke Sasaki; Takao Masaki; Tomoichiro Asano; Akifumi Kushiyama
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.